drugset / Trial / NCT02595528
A Study of the Concurrent Use of AGN-190584 and AGN-199201 in Participants With Presbyopia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will identify the optimum concentrations of AGN-199201 and AGN-190584 when dosed in combination once a day for the improvement of uncorrected near visual acuity in participants with presbyopia (inability to focus on items close-up).
Timeline
- Start
- 2016-04-29
- Primary completion
- 2017-10-18
- Completion
- 2017-10-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AGN-190584 | Unknown | — | Other |
| Subject | Oxymetazoline | Other / unclassified | — | Other |